Diagnostic Dermatology Imaging Devices Market Size, Share & Trends Analysis Report By Modality (Advanced Diagnostic Imaging Systems, Biopsy Devices), By Application (Skin Cancer, Inflammatory & Autoimmune), By End Use, By Region, And Segment Forecasts, 2025 - 2030

 Market Size & Trends

The global diagnostic dermatology imaging devices market size was estimated at USD 4.93 billion in 2024 and is projected to grow at a CAGR of 9.4% from 2025 to 2030. The growing prevalence of skin disorders, rising awareness about skin cancers, and the growing demand for non-invasive diagnostic procedures are the factors affecting the market's growth. There is a significant rise in the number of skin cancer cases globally, which drives the need for advanced solutions to facilitate better cancer care. For instance, in February 2025, Canfield Scientific introduced the new D2 Digital Dermatoscope, which has a high-resolution display, and its design enhances ease of use and elevates the user experience. It enables consistent, standardized imaging for accurate documentation and precise diagnostics.

The increasing prevalence of skin disorders and skin cancers significantly drives the growth of the diagnostic dermatology imaging devices market. Skin cancer, including melanoma and non-melanoma types such as basal cell carcinoma and squamous cell carcinoma, continues to rise globally due to factors like prolonged UV exposure, aging populations, and enhanced awareness and screening efforts. According to the American Academy of Dermatology, skin cancer is most prevalent in the U.S.; approximately 9,500 people are diagnosed with skin cancer daily, and over 1 million individuals are currently suffering from melanoma.

Furthermore, the Global Cancer Observatory (GLOBOCAN) reports that the number of skin melanoma cases is expected to increase to 599,565. Skin cancers are predominantly found in women under the age of 50, but they occur significantly more frequently in men over the age of 50. This discrepancy can be attributed to differences in recreational and occupational UV exposure. Estimates suggest that around 1 in 27 men and 1 in 40 women are expected to suffer from melanoma.

Number of Melanoma of Skin Cases in Men and Women from 2022 to 2030

Source: International Agency for Research on Cancer (IARC), GVR Analysis

The growing awareness of early disease diagnosis has emerged as a critical driver in healthcare, particularly in fields like dermatology, where early intervention can significantly improve patient outcomes. Increased public education, widespread use of digital health platforms, and a greater understanding of skin cancer risks empowered individuals to seek medical attention sooner, creating a demand for accurate, non-invasive diagnostic tools. This trend is particularly significant for detecting conditions such as melanoma, where early identification can be lifesaving. Consequently, dermatology clinics, hospitals, and even primary care providers increasingly adopt advanced imaging technologies to address the market demand.

This directly influences technological innovation and strategic activity within the companies operating in this market. For instance, in May 2023, Orlucent, Inc. received FDA Breakthrough Device Designation for its Skin Fluorescence Imaging System, which provides a non-invasive molecular analysis of moles. This approval marks a significant advancement in the market for diagnostic dermatology imaging devices. The handheld, non-invasive device uses a topically applied fluorescent peptide to detect αvβ3 integrin, which indicates early melanoma development. By offering molecular-level imaging and analysis of moles, the mSFI system allows clinicians to evaluate the biological tissue remodeling activity associated with atypical moles, thereby enabling the early detection of melanoma without requiring invasive procedures.

Additionally, the growing demand for non-invasive diagnostic approaches is fueling market expansion. Both patients and clinicians increasingly favor methods that eliminate the risks, discomfort, and downtime linked with conventional biopsies. This trend is particularly prominent in dermatology-especially skin cancer diagnosis-where early detection is vital. Techniques like optical coherence tomography (OCT), reflectance confocal microscopy (RCM), and dermoscopy deliver detailed skin lesion imaging, supporting accurate assessment and ongoing monitoring. 

Technological advancements have played a pivotal role in this transition. Devices like DermaSensor, which received FDA clearance in January 2024, utilize AI-powered spectroscopy to non-invasively assess skin lesions for potential malignancy. In clinical studies, DermaSensor demonstrated a sensitivity of 97% in detecting various skin cancers, including melanoma, basal cell carcinoma, and squamous cell carcinoma. Such innovations not only improve diagnostic accuracy but also reduce reliance on subjective clinical assessments, enabling more consistent and efficient evaluations. The further emergence of technologically advanced devices, such as hyperspectral dermatoscopes, offers a promising approach for non-invasive skin evaluation. These devices capture a broad range of wavelengths with high precision, identifying and characterizing various skin conditions. Preliminary results suggest that hyperspectral imaging can enhance diagnostic accuracy, providing a new platform for research and clinical applications in dermatology.

Market Concentration & Characteristics

The diagnostic dermatology imaging devices industry exhibits moderate industry concentration, with several key players dominating the market. Initiatives to raise awareness and knowledge about skin conditions and early diagnosis further stimulate market growth.

The diagnostic dermatology imaging devices industry is characterized by high innovation. Notable innovations have included traditional dermoscopy, AI-powered diagnostic tools, teledermatology platforms, and 3D imaging. These innovations primarily focus on improving the early detection of skin cancers, particularly melanoma, and making diagnostics more accurate and accessible through mobile devices and cloud-based solutions. Companies are also integrating machine learning algorithms to assist clinicians in making more consistent and objective decisions.

Regulatory frameworks significantly influence the diagnostic dermatology imaging devices industry, as these products are classified under medical devices in most regions. Compliance with regulatory requirements, such as US FDA guidelines or EU CE marking, is imperative for market entry and consumer trust. These regulations govern various aspects, including product design, manufacturing processes, and post-market surveillance, influencing product development timelines and market access. Evolving regulatory landscapes necessitate continuous monitoring and adaptation by industry players to ensure compliance and navigate market dynamics effectively.

Mergers and acquisitions in the diagnostic dermatology imaging devices industry are rising due to the need for research and development, reflecting the industry's dynamic nature. Companies engage in mergers and acquisitions to expand their product portfolio, enter new markets, acquire cutting-edge technologies, and achieve economies of scale. Such acquisitions aim to expand portfolios, gain AI capabilities, or access new markets. There is a consistent interest in both traditional and medical device players and tech companies looking to enter the digital health and skin diagnostics space.

The diagnostic dermatology imaging device industry faces competition from traditional and emerging imaging methods. Conventional dermatology imaging devices and systems, such as conventional dermatoscopes, remain prevalent due to their cost-effectiveness and simplicity. However, digital and advanced dermatoscopes offer advantages such as camera attachments or built-in digital capture, image storage, comparison over time, basic lesion analysis, and teledermatology use, which drive their adoption. However, the high cost of such imaging devices and the need for specialized training can limit their acceptance in certain markets.

The diagnostic dermatology imaging devices industry is expanding globally, with North America and Europe leading in adoption due to advanced healthcare infrastructure, higher awareness, and regulatory clarity. Asia-Pacific is emerging rapidly, especially in urban centers of China, Japan, South Korea, and India, driven by rising skin cancer rates, improving healthcare access, and the growing presence of telehealth platforms. For instance, in May 2024, efforts by Melanoma Latinoamérica and Melanoma Uruguay emphasized the urgent need for public education on skin cancer prevention and the importance of early diagnosis through digital imaging tools.

Modality Insights

The advanced diagnostic imaging devices segment accounted for the largest revenue share of 40.4% in 2024. Technological advancements and increasing demand for non-invasive diagnostic methods drive the advanced diagnostic imaging devices segment in the dermatology imaging devices market. The advanced diagnostic imaging devices include Optical Coherence Tomography (OCT) Devices, Reflectance Confocal Microscopy (RCM) Devices, high-frequency ultrasound devices, and others. Innovations in these devices enhance the accuracy of skin cancer detection and improve patient outcomes by enabling detailed imaging of skin structures.

The molecular diagnostic devices & platforms segment is expected to grow at the fastest CAGR of 11.4% over the forecast period. The increasing demand for early, precise, and non-invasive skin disease detection methods drives this segment. These platforms enable clinicians to identify specific molecular markers associated with skin cancers, inflammatory conditions, and genetic dermatologic disorders, as these molecular diagnostic platforms, such as PCR-based systems, Next-Generation Sequencing (NGS), and microarray technologies, provide detailed insights into the genomic and proteomic levels. Integrating molecular diagnostics with dermatologic imaging enhances diagnostic accuracy, helping differentiate between benign and malignant lesions with better accuracy. This growing clinical preference for molecular-level insights encourages healthcare facilities and dermatology labs to adopt such platforms to enhance traditional imaging modalities.

Application Insights

The skin cancer segment accounted for the largest revenue share of 48.6% of the diagnostic dermatology imaging devices market in 2024. Market growth is driven by the increasing prevalence of melanoma and non-melanoma skin cancers, such as Squamous Cell (SCC) and Basal Cell (BCC) carcinomas. Skin cancer is one of the most common forms of cancer in the U.S. Furthermore, according to the American Academy of Dermatology Association, current estimates indicate that one in five Americans will be diagnosed with skin cancer each day in the U.S. In May 2024, a new EU-funded portable skin cancer screening device, developed by researchers in Latvia, aimed to revolutionize melanoma detection. This device uses LED lights to analyze skin lesions based on chromophore reflections and sends images to an AI-powered cloud system for rapid results.

The wound and ulcer segment is expected to grow significantly over the forecast period. This growth is fueled by the increasing prevalence of chronic wounds and ulcers, particularly among aging populations. Chronic wounds, such as diabetic foot ulcers and pressure ulcers, pose significant healthcare challenges due to their complex nature and longer healing times. These conditions require continuous monitoring and documentation to track healing progress and optimize treatment plans. Furthermore, the rising incidence of diabetes and vascular diseases is another factor driving the growth of wound and ulcer assessment. For instance, the latest IDF Diabetes Atlas (2025) indicates that 11.1% of adults aged 20-79, or 1 in 9, are living with diabetes, with over 40% unaware of their condition.

End Use Insights

The hospitals segment held the largest revenue share in the diagnostic dermatology imaging devices market in 2024. Hospitals increasingly invest in advanced imaging technologies such as dermatoscopes, confocal microscopy, photographic imaging systems, and high-resolution ultrasounds to enhance their diagnostic capabilities.The growth of this segment is significantly influenced by the increasing prevalence of skin disorders and the rising demand for early diagnosis. For instance, in November 2023, Allegheny Health Network (AHN)launched a cutting-edge melanoma and skin cancer center, incorporating advanced technologies like Vectra for 3D imaging. This innovative approach enhances patient care by providing detailed assessments of skin lesions, improving diagnosis and treatment planning for melanoma and other skin cancers.

The dermatology clinics/centers market is expected to grow significantly during the forecast period. Dermatology clinics are increasingly adopting high-resolution imaging technologies that enhance the accuracy of skin disease diagnosis. As awareness about skin health rises among the general population, patients are more inclined to seek specialized care at dermatology clinics that utilize effective diagnostic tools. These clinics typically handle many dermatological conditions, ranging from common skin issues to complex malignancies, making diagnostic imaging tools necessary.

Regional Insights

The North American diagnostic dermatology imaging devices market dominated the global market and accounted for a 41.9% revenue share in 2024. Some key factors contributing to the growth include the increasing incidence of cancer and other skin conditions, heightened awareness of early disease detection and treatment, and the availability of advanced technologies and imaging modalities that facilitate dermatologists' ability to diagnose and treat skin disorders.Additionally, there is a growing patient preference for non-invasive diagnostic procedures, which offer detailed assessments without the discomfort associated with traditional biopsies.Moreover, the integration of teledermatology has expanded access to specialized care, particularly in remote areas, by allowing high-quality images to be captured and transmitted for expert analysis.

U.S. Diagnostic Dermatology Imaging Devices Market Trends

The diagnostic dermatology imaging devices market in the U.S. held a significant share of North America's diagnostic dermatology imaging devices market in 2024, driven by factors such as the rising incidence of skin cancer, the growing prevalence of skin disorders, and technological advancements. Innovations such as high-resolution imaging, AI integration, 3D visualization, optical coherence tomography, digital photography, and high-frequency ultrasound have enhanced dermatologists’ diagnostic capabilities. For instance, in April 2024, researchers from Stanford Medicine discovered that artificial intelligence, particularly deep learning-based computer algorithms, improves the accuracy of skin cancer diagnoses among healthcare professionals.

Europe Diagnostic Dermatology Imaging Devices Market Trends

The European diagnostic dermatology imaging devices market is witnessing growth fueled by the increasing prevalence of chronic diseases, technological advancements, and regulatory support for innovative imaging systems. Countries such as Germany, France, and the UK are at the forefront of this expansion, with strong healthcare infrastructure and favorable reimbursement policies accelerating the adoption of diagnostic dermatology imaging devices and reducing dependency on healthcare facilities.

The diagnostic dermatology imaging devices market in the UK is one of the key markets in the region. The rising incidence of skin disorders has increased the demand for advanced diagnostic tools. Furthermore, technological advancements and the shift in healthcare dynamics drive the market. Technological innovations, such as integrating artificial intelligence (AI) in imaging devices, have enhanced diagnostic accuracy and efficiency. The British Skin Foundation reports over 100,000 new skin cancer cases annually in the UK. One in five children has eczema. Further, at least 60% of people in the country have a skin condition or previously had one. This increases the need for advanced, accurate, and non-invasive diagnostic tools.

France's diagnostic dermatology imaging devices market is expected to grow over the forecast period. The rising prevalence of skin disorders, such as psoriasis, eczema, and atopic dermatitis, requires specialized imaging devices to diagnose these conditions, which is driving the growth of the market in the country. France's robust healthcare infrastructure and emphasis on early detection have fostered an environment conducive to adopting advanced imaging technologies. For instance, in February 2024, Pierre Fabre Laboratories announced a global study on the epidemiology of acne in the Journal of the American Academy of Dermatology (JAAD).

According to key personnel of the Avène Dermatological Laboratories member, “This study represents a breakthrough in deepening our understanding of the different etiological factors of acne. It opens the way to new prevention and treatment strategies for this chronic skin condition by taking into account the lifestyles and specificities of each population.”

These advancements highlight France's proactive approach to adopting cutting-edge dermatological imaging technologies, which is driven by a commitment to early diagnosis and improved patient care.

The diagnostic dermatology imaging devices industry in Germany is projected to expand in the forecast period. Germany’s diagnostic dermatology imaging devices market is witnessing significant growth due to technological advancements, a high prevalence of skin conditions, and strategic industry collaborations. For instance, in January 2024, Karl Storz SE & Co. KG acquired London-based software manufacturer Innersight Labs Ltd. to enhance its imaging capabilities, particularly in integrating augmented reality into diagnostic procedures.

Italy diagnostic dermatology devices market is projected to expand in the forecast period due to increasing demand for advanced therapeutic solutions, particularly for chronic disease management. Companies operating in the country’s market, such as Canfield Scientific, Inc., are undertaking various initiatives to increase their presence, fueling market growth. Canfield Scientific, Inc., a key player in the diagnostic dermatology imaging devices market, acquired Medici Medical s.r.l, a key player in dermoscopy innovations and solutions.

Asia Pacific Diagnostic Dermatology Imaging Devices Market Trends

The diagnostic dermatology imaging devices market in the Asia Pacific region is projected to experience the fastest growth during the forecast period. China and Japan are expected to dominate this market. Additionally, the availability of trained professionals and the development of healthcare facilities are anticipated to contribute significantly to market growth.Furthermore, the increasing disposable income of people in Asia is expected to increase the demand for dermatology imaging devices.

Japan diagnostic dermatology devices market will expand in the forecast period. Japan's well-developed healthcare infrastructure and the availability of advanced medical devices have contributed to the market's expansion. The increasing prevalence of skin disorders, including acne, eczema, psoriasis, and skin cancer, has fueled the demand for dermatology imaging devices. Notably, the incidence of skin cancer, particularly melanoma, has been on the rise in recent years, necessitating the use of advanced imaging techniques for early detection and diagnosis.

In April 2023, Shimadzu Corporation showcased its latest medical imaging technologies at the International Technical Exhibition of Medical Imaging (ITEM 2023) in Yokohama. The exhibition emphasized innovations to improve examination efficiency, enhance visualization, and reduce operator workloads.

The diagnostic dermatology imaging devices market in China is expected to grow over the forecast period. Technological advancements and rising healthcare infrastructure drive the market in China. Technological advancements have led to more advanced imaging devices that offer greater accuracy and resolution, while increasing healthcare expenditure has enabled more patients to access dermatology services.The increasing prevalence of skin conditions such as acne, psoriasis, eczema, and skin cancer is significantly influencing the growth of the dermatology imaging devices market.For instance, according to the Global Cancer Observatory (GLOBOCAN), the 5-year prevalence of melanoma in the country is 29,059, and the incidence of melanoma of the skin in 2030 is expected to reach 10,568.

India diagnostic dermatology imaging devices market is expected to grow over the forecast period.The market is experiencing significant expansion, driven by the rising prevalence of skin conditions, preference for non-invasive diagnostics, technological advancements, and certain government initiatives or collaborations to boost the growth of diagnostic imaging in the country.Significant investments and initiatives are also shaping the overall market landscape of medical devices. For instance, in March 2024, Wipro GE Healthcare announced a USD 960 million investment in India's manufacturing and research and development facilities over the next five years, aiming to boost local manufacturing and align with the government's "Make in India" initiative.

Latin America Diagnostic Dermatology Imaging Devices Market Trends

The increasing burden of skin cancer and rising awareness about early detection in the region drive Latin America's diagnostic dermatology imaging devices market. Over the past two decades, skin cancer incidence in Latin America has risen steadily due to prolonged exposure to ultraviolet (UV) radiation, a consequence of both geographic positioning and lifestyle factors such as outdoor activities and tanning culture.Additionally, recent studies, such as the BRAF-Mutated Melanoma Journey in Latin America (published in 2024), show rising melanoma incidence and mortality, with many patients diagnosed at stage IV. This highlights the necessity of diagnostic advancements, including BRAF-mutation testing and imaging devices, for earlier detection and personalized treatment.

Middle East & Africa Diagnostic Dermatology Imaging Devices Market Trends

Rising skin cancer and other skin conditions, increasing adoption of advanced surgical techniques, and growing healthcare infrastructure are the factors driving the Middle East and Africa diagnostic dermatology imaging devices market. A pivotal study, first published in November 2024, from a tertiary care center in Lebanon reinforces this trend, highlighting the region's growing competence in skin cancer management.Consequently, the Middle East & Africa diagnostic dermatology imaging market is expected to expand steadily, fueled by regional clinical advancements, aging populations, and rising skin cancer awareness. These developments present strong growth opportunities for device manufacturers seeking to support skin cancer diagnosis and surgical planning in emerging healthcare markets.

The diagnostic dermatology imaging devices industry in Saudi Arabia is anticipated to expand in the forecast period. The factors affecting market growth include advancements in medical technology and the rising prevalence of skin conditions, such as skin cancer, psoriasis, and eczema. For instance, eczema or atopic dermatitis, which is highly prevalent in Saudi Arabia, affects approximately 13.1% of college students.The country's extreme climate-high temperatures and low humidity-exacerbates skin conditions, increasing the demand for effective diagnostic and treatment solutions.

Kuwait diagnostic dermatology imaging devices market is expected to witness moderate growth, driven by higher healthcare spending, growing awareness of health, and investments in healthcare infrastructure. Furthermore, the increasing awareness and the need for early detection of skin cancers also drive the market's growth. A 13-year study in Kuwait (Dec 2023) found that basal cell carcinoma (84.2%) and squamous cell carcinoma (15.8%) were the main non-melanoma skin cancers, mostly on sun-exposed areas. With an average patient age of 64.9, the study highlights the need for better screening in older adults and improved diagnostic tools. These findings underscore the necessity for advanced diagnostic tools in dermatology.

Key Diagnostic Dermatology Imaging Devices Company Insights

The diagnostic dermatology imaging devices market is highly competitive. Key players such as Canfield Scientific, Caliber Imaging & Diagnostics, SciBase AB, Damae Medical, DermaSensor Inc., and Michelson Diagnostics (MDL) hold significant positions.

Leading companies are pursuing a mix of organic and inorganic strategies, including new product development, partnerships, acquisitions, mergers, and regional growth, to address the unmet demands of their customers.

Recent Developments

• In March 2025, Damae Medical, a developer of cutting-edge imaging devices and AI-driven solutions that offer exceptional diagnostic support for dermatologists, announced that its deepLive medical device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

• In February 2025, Apollo Medical Optics, Ltd. (AMO) entered into a distribution partnership with Japan-based Integral Corporation, a key player in dermatology, aesthetics, and skin research equipment. With the fulfillment of its first order, AMO successfully marked its entry into the Japanese market.

• In May 2024, SciBase Holding AB unveiled the eBarrier Score, a groundbreaking AI-driven skin barrier assessment tool tailored for research and cosmetic testing. This launch was officially announced at the Cosmetotest symposium on cosmetic testing in Lyon France.

• In January 2024, DermaSensor Inc. announced that the FDA granted clearance for its real-time, non-invasive system designed to evaluate skin cancer. This marks the first opportunity for the 300,000 primary care physicians throughout the U.S. to provide quantitative, point-of-care testing for all skin cancer types, thereby improving early detection capabilities in primary care settings.

Diagnostic Dermatology Imaging Devices Market Report Scope

Global Diagnostic Dermatology Imaging Devices Market Report Segmentation

This report forecasts country-level revenue growth at global, regional, and country level and analyzes the latest industry trends and opportunities in each sub-segment from 2018 to 2030. For this study, Grand View Research has segmented the global diagnostic dermatology imaging devices market report based on the modality, application, end use, and region:

• Modality Outlook (Revenue, USD Million, 2018 - 2030)

  • Advanced Diagnostic Imaging Devices

    • Optical Coherence Tomography (OCT) Devices

    • Reflectance Confocal Microscopy (RCM) Devices

    • High-frequency Ultrasound Devices

    • Others

  • Surface Visualization Devices

    • Dermatoscopes

    • Photographic Imaging Systems

    • Others

  • Biopsy Devices

  • Molecular Diagnostic Devices & Platforms

• Application Outlook (Revenue, USD Million 2018 - 2030)

  • Skin Cancer

    • Melanoma

    • Non-melanoma

  • Inflammatory & Autoimmune Skin Diseases

    • Psoriasis

    • Eczema/Atopic Dermatitis

    • Others

  • Infectious Skin Conditions

  • Wound & Ulcer Assessment

• End Use Outlook (Revenue, USD Million 2018 - 2030)

  • Hospitals

  • Dermatology Clinics/Centers

  • Cancer Centers/Oncology Clinics

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait